We want to help patients receive the right care.

Minimizing bias in clinical trials is essential to ensure that the correct conclusions are drawn and patients receive the right care. Pharmaceutical companies fund a significant number of major clinical trials but are subject to a potential conflict of interest due to their clearly stated financial objectives.

Therefore, these companies must conduct research to a very high standard to ensure that the results are accurate and conclusions correct. They must then publish all their trials in peer-reviewed scientific journals to ensure that the trials can be critically appraised and retested where needed by other researchers.

Although publication of trial data is now widely accepted, reporting all results for all trials is not done in reality. Yet, for a potentially conflicted environment like the pharmaceutical industry, reporting all trials is extremely important to ensure full transparency and to minimize potential bias.